病灶小于5 cm宫颈癌26例术前化疗效果观察(2)
 |
| 第1页 |
参见附件(2299KB，3页)。
参 考 文 献
[1] 董志伟,谷铣之.临床肿瘤学.人民卫生出版社,2002:118-1216.
[2] 孙燕,石远凯.临床肿瘤内科手册.人民卫生出版社,2007:626-639.
[3] Duenas-Gonzalez A,Lopez-Graniel C,Gonzalez,A,et al.A phase Ⅱ study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma.Ann Oncol,2001,12(2):541-547.
[4] 刘萍,陈春林,曾北英,等.宫颈癌术前动脉化疗的组织学病理学动态变化及临床结局.中国实用妇科与产科杂志,2006,22(2):109-110.
[5] Jvanov S,Zervudis S,Ivanov S.Metastatic cancer in transposed ovaries after radical Wertheia-Meigs hysterectomy for a stageⅠb and Ⅱa cervical cancer.Akush Ginekol(Sofua),2003,42(5):22-24.
[6] Toita T,Mitsuhashi N,Teshima T,et al.Postoperative radiotherapy for uterine cervical cancer:results of the 1995-1997 patterns of care process survey in Japan.Jpn J Clin Oncol,2004,34(2):99-103.
[7] 李联昆,李雪梅,张新.宫颈癌近期治疗失败40例分析.中国实用妇科与产科杂志,2006,22(4):277-278.
[8] Aoki Y.Tomita M,Sato T,et al.Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcincma of the cervix.Gynecol Oncol,2001,83(2):263-267.
[9] Zanetta G,Lissoni A.Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vagjnal adenocarcinoma.Gynecol Oncol,2007,74(5):1431-1436.
您现在查看是摘要介绍页，详见PDF附件(2299KB，3页)。